SCHEMBL8910063

SCHEMBL8910063

Cc1ccccc1OCC(O)CN1CC=C(c2ccccc2)CC1.OC(COc1cccc(C(F)(F)F)c1)CN1CC=C(c2ccccc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.59
ALDH1A1 P00352 2/20 0.59
KDM4E B2RXH2 1/20 0.59
GAA P10253 1/20 0.59
MAPT P10636 1/20 0.59
ALOX15 P16050 1/20 0.59
TSHR P16473 1/20 0.59
PRMT5 O14744 13/20 0.56
WDR77 Q9BQA1 13/20 0.56
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CYP2D6 P10635 1/20 0.47
THPO P40225 1/20 0.47
PMP22 Q01453 1/20 0.46
SCN1A P35498 1/20 0.46
SCN5A Q14524 1/20 0.46
SCN9A Q15858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7864713 0.92 LMNA (0.66) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL7854720 0.86 CYP2D6 (0.61) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL7854934 0.86 LMNA (0.67) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL7861680 0.82 TSHR (0.73) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL8910069 0.81 LMNA (0.53) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL7865141 0.79 LMNA (0.66) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL8702329 0.76 LMNA (0.57) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL12618637 0.76 CYP2D6 (0.74) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL7854831 0.76 LMNA (0.58) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL7862516 0.74 MAPT (0.62) LMNAALDH1A1KDM4EGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5698565-A TREATMENT OF PSYCHOTIC DISORDERS HOFFMANN-LA ROCHE INC. (US) 1997-12-16 US disclosed